High cost oncology drugs without proof of added benefit are burdening health systems

DSpace/Manakin Repository

High cost oncology drugs without proof of added benefit are burdening health systems
 
Brinkhuis, Francine; Goettsch, Wim Gerrit; Mantel - Teeuwisse, Aukje; Bloem, Lourens T
(2024) The BMJ, volume 384
(Comment)
Download/Full Text
Open Access version via Utrecht University Repository Publisher version
 
Keywords: Taverne, General Medicine
DOI: https://doi.org/10.1136/bmj.q511
ISSN: 1756-1833
Publisher: BMJ Publishing Group Ltd
(Non peer reviewed)
 
 
See more statistics about this item